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Abstract
Purpose:To compare the five vena caval filters marketed in
the United States and one investigational vena caval filter
and to determine whether there is an association between
their design and their in vivo function.
Methods:Four of each type of filter—Simon Nitinol (SN),
Bird’s Nest (BN), Vena Tech (VT), Greenfield stainless steel
(PSGF), Greenfield titanium (TGF), and the investigational
stent cone filter (NGF)—were studied for 60 days in 12
sheep. Radiographic and pathologic outcomes to be assessed
included clot capture and resolution, vena caval penetration,
position of the filter, thrombogenicity, and vessel wall reac-
tion.
Results:Filters differed with respect to the number of clot-
trapping levels and the interdependence of the legs. All
devices were successfully placed. Intentionally embolized
clot was captured. One VT and two SN filters migrated in
response to clot capture. Resolution of thrombus was vari-
able, and related to the design of the device. Fibrin webbing
was widely present with the VT, BN, and SN filters but
limited in the others. The VT and NGF filters demonstrated
the most stable filter base diameter.
Conclusions:The performance of vena caval filters differs
with respect to clot resolution and mechanical stability.
Interdependent filter limbs and single-stage conical capture
sites appear to result in more favorable performance in in
vivo studies.
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An ideal vena caval filter must combine the ability to capture
clinically significant emboli while maintaining the patency
of the vena cava. In addition, it must be mechanically stable.
An investigational filter has been developed by the Boston
Scientific Vascular Division (BSC, Natick, MA, USA) and
in this study we compared it with the filters currently ap-
proved for the US market to determine the extent to which it
meets these criteria (Table 1).
The investigational “stent cone” filter, referred to as the
NGF, has a unique design incorporating the traditional
Greenfield cone combined with a stent base. It is manufac-
tured of nitinol wire to allow compression into a 9 Fr
delivery system. The cone portion of the NGF is comparable
in volume to the original Greenfield filter. At 55 mm it is the
longest of the BSC filters. Its 32-mm resting base diameter is
similar to the titanium Greenfield filter (TGF) at 38 mm and
the percutaneous stainless steel Greenfield filter (PSGF) at
32 mm (Fig. 1). Our purpose was to compare performance
with respect to clot capture, clot resolution, thrombogenicity,
migration, filter stability, and histologic effects on the vena
cava.
Materials and Methods
The study was conducted in the Greenfield Vascular Research
Laboratory under approval by the University Committee on the Use
and Care of Animals and according to Federal regulations. The six
devices included the Bird’s Nest filter (BN; Cook, Bloomington,
IN, USA), the Greenfield filters (PSGF, TGF, NGF, Boston Scien-
tific/Meditech, Natick, MA, USA), the Simon Nitinol filter (SN;
Bard, Boston, MA, USA) and the VenaTech filter (VT; Braun,
Evanston, IL, USA). Two devices of each type were placed in each
of 12 sheep weighing at least 34 kg, one above and one below the
renal vein according to the matrix in Table 2. All were placed via
the right femoral vein using a prototype 9 Fr transit delivery system.
Plain films and cavograms with intravenous contrast were ob-
tained in the anteroposterior and lateral projections both prior to
and following filter placement, following intentional embolization
and just prior to necropsy. Autologous clot for embolization was
produced by adding thrombin to 20 ml of blood drawn from each
animal. The blood was placed in a 35-cm3 9-mm-diameter tube
and aged for 24 hr. Five grams of clots were divided into 100-
mm 3 9-mm segments and released into the femoral vein of six
animals via a 50-ml syringe with a modified tip inserted through a
femoral venotomy (Table 2) at the time of filter placement. Move-
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ment of the filter during clot challenge was observed under fluo-
roscopy and measured from post-capture plain films. The animals
were recovered and returned to the housing facility for a 60-day
survival period. At necropsy, the vena cavas were perfusion-fixed
with formalin. After explant, they were photographed from a lat-
eral, cranial and caudal aspect, then opened lengthwise. All filters
were examined by a pathologist who was responsible for charac-
terizing thrombus, caval penetration by filter components, filter leg
distribution, and fixation site tissue reaction. Histology samples
were prepared of tissue found at the fixation site and trapped on or
within the filter.
The BN filter differs from the others in that it is free-formed
continuous wire without a defined shape. For this reason, we did not
include it in assessments of centering or symmetry.
Filter leg attachment was characterized as being independent if
the legs were free of one another, while dependent indicated a
physical connection in such a manner that movement of one leg
resulted in movement of the others (Table 1). Criteria for deter-
mining clinically important movement were based on standards
accepted by the US Food and Drug Administration (FDA) in the
1995 Greenfield Stainless Steel Filter marketing approval submis-
sion and included longitudinal movement.20 mm or filter base
increase.7 mm.
Data were entered into case reporting forms and analyzed using
Systat 5.1 (Systat, Evanston, IL, USA). The study was designed to
identify large differences among the devices. Due to the small
sample size, nonparametric tests were used to analyze continuous
variables while likelihood ratio chi-squares or Fisher’s Exact test
were used with dichotomous data. A nonparametric ANOVA was
performed initially to determine whether there were differences
among the devices. When significant, further comparisons were
done to identify the direction of the differences.
Results
Animals were comparable in weight (48–52 kg) and caval
diameter (17–20 mm) (p . 0.05), thus avoiding potential
Fig. 1. A The three traditional Greenfield filters: original
stainless steel (left), titanium (center), percutaneous steel
(right), and the investigational device (far right) which com-
bines the advantages of a cone with the reduced delivery
profile. B The Vena Tech (left), Simon Nitinol (center) and
Bird’s Nest (right) filters marketed in the United States.















Bird’s Nest (Cook) BN Multiple Independent
Simon Nitinol (Bard) SN Dual Independent
VenaTech (B. Braun) VT Single Dependent
aSee Materials and Methods
Table 2.Study design for placement and clot challenge: study design matrix
with type of filter location and whether it underwent intentional clot em-




1 NGF IR Yes
VT SR No
2 NGF IR No
SN SR No
3 PSGF IR Yes
BN SR No
4 PSGF IR No
VT SR No
5 TGF IR Yes
SN SR No
6 TGF IR No
BN SR No
7 VT IR Yes
TGF SR No
8 VT IR No
PSGF SR No
9 SN IR Yes
NGF SR No
10 SN IR No
TGF SR No
11 BN IR Yes
PSGF SR No
12 BN IR No
NGF SR No
aIR 5 infrarenal; SR5 suprarenal
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bias. All filters were successfully placed according to the
manufacturer’s directions.
Clot Capture, Thrombogenicity, and Resolution
Each of the challenged filters trapped all the autologous
emboli while maintaining vena cava flow. There was prox-
imal movement of an infrarenal VT and SN filter of 9 mm
and 5 mm respectively in response to the challenge as
observed under fluoroscopy and measured from pre- and
post-challenge plain films. Thrombus resolution was evalu-
ated by venacavography and visual inspection at 60 days.
Residual clot was found in two SN, one BN, one NGF, and
one TGF filters (p 5 0.58)(Fig. 2). In all but two cases, the
pathologist characterized the thrombus as post-mortem due
to its lack of organization. However, two SN filters had
pathologic evidence of organized thrombus, one of which
had been challenged with autologous clot and one formed
spontaneously.
Filter Position and Stability
Centering of the filter within the vena cava was determined
from cavograms, on the basis of the relationship between the
apex of the filter and walls of the vena cava. The VT filter
demonstrated the most optimal centering based on the
cavograms. Symmetric distribution of the filter legs was
determined in two ways: contrast venacavography and actual
measurement of inter-leg spacing of specimens obtained at
necropsy. Following placement, there was a difference
among the devices with respect to the leg distribution, with
the NGF having the poorest performance (p 5 0.014).
However, at explant, the filter legs were well distributed and
we failed to find differences among devices by either mea-
surement technique (p 5 0.09).
The PSGF, NGF, and VT filters demonstrated the greatest
overall resistance to movement. Table 3 demonstrates the
mean movement, which was not statistically different among
filters. We also measured changes in base diameter of the
filters and failed to find a statistical difference (p 5 0.07).
However, there was a trend favoring the NGF (1.7 mm)
while the BN filter had the greatest change (7.3 mm). One
characteristic of the BN device not previously reported is the
possible distortion it causes to the vena cava. Figure 3
demonstrates the manner in which it twists the cava as it
becomes incorporated in the wall.
Pathology and Histology
Examination of the apex of each filter demonstrated a vari-
able degree of fibrin covering (Fig. 4) which was confirmed
by the pathologist. The amount varied with the design of the
device and was increased when the apex was in direct
contact with the vessel wall. The effect of attachment of the
filter to the vessel wall differed among devices. The VT and
NGF filters were associated with the least disruption to the
external surface of the cava (Fig. 5) while the hooks of the
PSGF, TGF, SN, and BN filters had various degrees of
externalization [1]. The cava frequently appeared to be “tent-
Fig. 2. Clot is seen under the wire of the BN filter and around the spindle of the SN filter. There is clot debris on the struts
of the VT filter and a small clot at the apex of the NGF.
Table 3. Summary of mean movement of filters documented over a 60-day







SN 9 (16.9) 4.3 (3.8) 3.8 (2.2)
VT 4 (4.1) 1.7 (1.1) 5.5 (3)
BN 12 (16.4) 7.3 (3.2) N/A
NGF 1 (2.7) 1.7 (1.3) 4.3 (1.9)
PSGF 1 (1.4) 4 (4.2) 5.86 (3.8)
TGF 20 (17.9) 4.4 (0.5) 5.3 (3.5)
aMovement less than 21 mm is considered to be clinically insignificant
Fig. 3. The wires of the BN filter appear to distort the vena
cava.
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ed” in response to radial force. If a hook penetrated slowly it
became encapsulated in a fibrous nodule which protected
adjacent tissue, as we have previously reported [2]. Often,
the caval wall stretched behind the independent filter limbs
and enclosed them, which also provided protection to exter-
nal organs. In these cases, the measured filter base diameter
increased but the true caval diameter remained unchanged.
Discussion
The similarity of vena caval filters is frequently suggested
[3–5]. The SN and VT devices even obtained FDA approval
based on inferred equivalence to the Greenfield filters during
a 510K approval process. This prospective in vivo study
suggests that this may not be true in all areas. All the devices
were successfully deployed and captured clinically signifi-
cant emboli. However, the VT and SN filters moved follow-
ing clot capture. This tendency may result in clinical
sequelae if the final resting place is inappropriate [6–10].
Cavograms obtained immediately prior to necropsy failed to
show any retained clot. However, at necropsy, several filters
had clot in various stages of resolution and the extent of
fibrin deposition in response to resolution differed signifi-
cantly (Fig. 6). The higher rates of filter and caval occlusion
reported in the literature with the VT and SN filters may be
related to fibrin webbing, the extent of which can limit caval
blood flow [11, 12]. It is unclear whether a filter needs to be
perfectly centered within the vena cava to be effective [13],
but with respect to this criterion, the NGF and VT filters
were the most consistently centered. These devices share the
design characteristic of inter-leg dependence: movement of
one leg results in movement of one or more of the others but
also limits the total amount of movement that can occur. The
fixed base appears to promote centering as well as limiting
caval penetration.
Changes in filter base diameter are frequently used as a
surrogate for caval penetration. Devices with independent
legs (PSGF, TGF, SN, BN) tended to have greater variability
than did the VT and NGF filters, whose diameters are fixed
by design. We were unable to correlate actual caval pene-
tration found at necropsy with change in filter base diameter
based on radiographs. Figure 7 depicts why the filter base
measurement overestimates the actual change in caval diam-
eter based on cavograms. The NGF and VT filters were also
associated with the least disruption to the wall of the vena
Fig. 5. The dependent legs and short hooks of the VT filter
limit caval penetration.
Fig. 4. A fibrin cap develops at the apex in most cases. Note the limited film on the NGF, PSGF, TGF, and VT filters as
compared with the heavy layering of the SN and BN filters.
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cava. These designs involve less intrusive attachment points
with greater reliance on radial force resulting in a more
stable diameter. We did note a tendency for the base of the
VT filter to pull away from the caval wall toward the center
of the cava as has previously been demonstrated [14, 15]
(Fig. 5). At the other extreme, the tip on the apex of two SN
filters had penetrated through the caval wall and a third
caused extreme tenting. Tilting of the second clot-trapping
level appeared to be responsible as it forced the apex tip
through the wall.
The significance of symmetric deployment of the filter
legs is discussed frequently [16–19]. Determination of leg
distribution at necropsy was much more informative than
radiographic images, which failed to account for the shape of
the vena cava and did not predict whether the cava was well
protected. The NGF had the highest incidence of asymmetry
at placement, but at explant and at necropsy there was no
difference among the devices. This may be due to the char-
acteristics of nitinol that favor its original configuration and
is not unlike the response we have seen with the titanium
filter. It may also signify early adjustment to the shape of a
vena cava that is not perfectly oval.
The gross pathologic examination showed other differ-
ences among the devices not previously reported. Both the
SN and BN filters are designed with more than one level for
clot capture. When these devices trap an embolus, it is often
in contact with the vessel wall and, as resolution takes place,
significant fibrin disposition develops. In the single-level
devices (PSGF, TGF, NGF), thrombus is held in the apex
allowing circumferential flow and increased resolution with
little webbing as the thrombus is not in contact with the
vessel wall. In vitro flow studies by Couch et al [20] have
provided an explanation for this effect. They found that the
design of a filter significantly affects flow velocity and wall
shear stress. A broad blunt face with near-wall contact leads
to reduced near-wall velocities and wall stress which can
increase the risk for thrombogenesis and vena caval occlu-
sion. They concluded that a centered cone provides optimal
flow.
In conclusion, vena caval filters differ with respect to
performance characteristics in this in vivo study. Our study
suggests that two design characteristics are associated with
hese differences: the interdependence of the leg attachment
and the number of clot-trapping levels. The investigational
filter incorporates a single level of apical clot trapping in
addition to a stent base which limits change in filter base
diameter. Its smaller attachment points result in less disrup-
tion of the caval wall. Unlike the VT filter with a cone apex
and stabilizing leg, the stent base reduces flow disturbance
within the vena cava, which reduces the risk of caval occlu-
sion. By relating experience with existing filter devices to
their design characteristics, new devices can be developed
that are closer to “ideal”.
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